A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)
Condition: HIV-1-infection Interventions: Biological: Vaccine and vedolizumab (Entyvio); Biological: Placebo vaccine and vedolizumab infusion (Entyvio); Biological: Placebo vaccine and placebo infusion Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); EuroVacc Foundation; European AIDS Treatment Group (EATG); Medical Research Council; University College London, UK.; University of L iverpool; Erasmus Medical Center; Henri Mondor University Hospital; European Georges Pompidou Hospital; Saint-Louis Hospital, Paris, France; Centre Hospitalier Universitaire Vaudois; Chelsea and Westminster Hospital, UK; Universitätsklinikum Hamburg-Eppendorf ; Hospital Clinic of Barcelona; Istituto Nazionale Malattie Infettive Lazaro Spallanzani; Imperial College London; Institut d'Investigacions Biomèdiques August Pi i Sunyer; European Commission; Swiss Government Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AIDS Vaccine | France Health | Government | Hepatitis | Hepatitis Vaccine | HIV AIDS | Hospitals | Research | Vaccines